The American Cancer Society and Genentech, a member of the Roche Group, are partnering to execute a $4 million collaborative effort to provide equitable access to every cancer patient and their families.
“We’ve always argued that money comes and goes, but if you lose a generation of scientists—you can’t buy them back,” said Kelvin Lee, director of the Indiana University Simon Comprehensive Cancer Center.
